| Primary |
| Acquired Immunodeficiency Syndrome |
21.7% |
| Antiviral Prophylaxis |
21.7% |
| Hiv Infection |
21.7% |
| Prophylaxis Against Hiv Infection |
21.7% |
| Meningitis Cryptococcal |
6.5% |
| Lymphadenopathy |
4.3% |
| Drug Use For Unknown Indication |
2.2% |
|
| Drug Exposure During Pregnancy |
20.0% |
| Ventricular Septal Defect |
13.3% |
| Hydrocele |
6.7% |
| Vomiting |
6.7% |
| Cryptorchism |
3.3% |
| Dyspnoea |
3.3% |
| Epidural Lipomatosis |
3.3% |
| Haemangioma Congenital |
3.3% |
| Hydrocephalus |
3.3% |
| Hypospadias |
3.3% |
| Live Birth |
3.3% |
| Lymphadenopathy |
3.3% |
| Micrognathia |
3.3% |
| Muscle Disorder |
3.3% |
| Neural Tube Defect |
3.3% |
| Polydactyly |
3.3% |
| Retrognathia |
3.3% |
| Stillbirth |
3.3% |
| Urinary Tract Obstruction |
3.3% |
| Weight Decreased |
3.3% |
|
| Secondary |
| Hiv Infection |
59.0% |
| Drug Exposure During Pregnancy |
13.6% |
| Acquired Immunodeficiency Syndrome |
8.3% |
| Drug Use For Unknown Indication |
7.2% |
| Hypertension |
2.3% |
| Prophylaxis |
1.3% |
| Cerebral Toxoplasmosis |
1.1% |
| Anaemia |
0.8% |
| Hiv Test Positive |
0.8% |
| Toxoplasmosis |
0.8% |
| Type 2 Diabetes Mellitus |
0.8% |
| Antiviral Treatment |
0.6% |
| Disseminated Tuberculosis |
0.6% |
| Accidental Exposure |
0.4% |
| Adult T-cell Lymphoma/leukaemia |
0.4% |
| Alcohol Abuse |
0.4% |
| Convulsion |
0.4% |
| Lymphadenopathy |
0.4% |
| Antibiotic Prophylaxis |
0.2% |
| Blood Pressure |
0.2% |
|
| Mesenteric Vein Thrombosis |
8.7% |
| Urine Abnormality |
8.7% |
| Drug Exposure During Pregnancy |
7.2% |
| Retrognathia |
7.2% |
| Tendon Rupture |
7.2% |
| Abortion Spontaneous |
5.8% |
| Intra-uterine Death |
5.8% |
| Tracheomalacia |
5.8% |
| Ventricular Septal Defect |
5.8% |
| Cryptorchism |
4.3% |
| Death |
4.3% |
| Sepsis |
4.3% |
| Vestibulitis |
4.3% |
| Hiv Infection Cdc Category B3 |
2.9% |
| Polydactyly |
2.9% |
| Premature Baby |
2.9% |
| Septic Shock |
2.9% |
| Small For Dates Baby |
2.9% |
| Trisomy 21 |
2.9% |
| Ultrasound Antenatal Screen Abnormal |
2.9% |
|
| Concomitant |
| Hiv Infection |
64.1% |
| Drug Use For Unknown Indication |
6.0% |
| Prophylaxis Against Hiv Infection |
5.0% |
| Maternal Therapy To Enhance Foetal Lung Maturity |
4.3% |
| Tuberculosis |
2.8% |
| Acquired Immunodeficiency Syndrome |
2.1% |
| Antiviral Treatment |
2.1% |
| Epilepsy |
2.1% |
| Antibiotic Prophylaxis |
1.4% |
| Ill-defined Disorder |
1.4% |
| Suppressed Lactation |
1.4% |
| Anaemia Prophylaxis |
1.1% |
| Infection |
1.1% |
| Mania |
1.1% |
| Prophylaxis |
1.1% |
| Cough |
0.7% |
| Hepatitis C |
0.7% |
| Hypertension |
0.7% |
| Adrenal Insufficiency |
0.4% |
| Bipolar Disorder |
0.4% |
|
| Drug Exposure During Pregnancy |
13.2% |
| Maternal Exposure During Pregnancy |
11.3% |
| Small For Dates Baby |
9.4% |
| Oesophageal Candidiasis |
7.5% |
| Premature Baby |
7.5% |
| Weight Decreased |
7.5% |
| Vomiting |
5.7% |
| Abortion Induced |
3.8% |
| Convulsion |
3.8% |
| Premature Rupture Of Membranes |
3.8% |
| Thrombocytopenia |
3.8% |
| Ultrasound Antenatal Screen Abnormal |
3.8% |
| Urticaria |
3.8% |
| Victim Of Spousal Abuse |
3.8% |
| Abortion Spontaneous |
1.9% |
| Blood Potassium Decreased |
1.9% |
| Caesarean Section |
1.9% |
| Cerebral Toxoplasmosis |
1.9% |
| Drug Ineffective |
1.9% |
| Drug Interaction |
1.9% |
|
